Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) Deferred Income Tax Expense (Benefit)

2.6 / 5 stars · 61/118 Roast Me

IQVIA HOLDINGS INC. Deferred Income Tax Expense (Benefit)

IQVIA HOLDINGS INC. (IQV) reported Deferred Income Tax Expense (Benefit) of -$38.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-05-05

  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$38.00M.
  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$48.00M.
  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$46.00M.
  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was -$45.00M.
  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for fiscal 2025 was -$180.00M.
  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for fiscal 2024 was -$129.00M.
  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for fiscal 2023 was -$269.00M.
  • IQVIA HOLDINGS INC. deferred income tax expense (benefit) for fiscal 2022 was -$115.00M.
Period endDeferred Income Tax Expense (Benefit) 3 monthDeferred Income Tax Expense (Benefit) 3 month as first filedDeferred Income Tax Expense (Benefit) 6 monthDeferred Income Tax Expense (Benefit) 6 month as first filedDeferred Income Tax Expense (Benefit) 9 monthDeferred Income Tax Expense (Benefit) 9 month as first filedDeferred Income Tax Expense (Benefit) 12 monthDeferred Income Tax Expense (Benefit) 12 month as first filed
2026-03-31-$38.00M
10-Q · filed 2026-05-05
-$86.00M
derived: sum of 2 quarters · filed 2026-05-05
-$132.00M
derived: sum of 3 quarters · filed 2026-05-05
-$177.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31-$48.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$94.00M
derived: sum of 2 quarters · filed 2026-02-17
-$139.00M
derived: sum of 3 quarters · filed 2026-02-17
-$180.00M
10-K · filed 2026-02-17
2025-09-30-$46.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
-$91.00M
derived: sum of 2 quarters · filed 2025-10-28
-$132.00M
10-Q · filed 2025-10-28
-$147.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-06-30-$45.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22
-$86.00M
10-Q · filed 2025-07-22
-$101.00M
derived: sum of 3 quarters · filed 2026-05-05
-$135.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-03-31-$41.00M
10-Q · filed 2026-05-05
-$56.00M
derived: sum of 2 quarters · filed 2026-05-05
-$90.00M
derived: sum of 3 quarters · filed 2026-05-05
-$104.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$49.00M
derived: sum of 2 quarters · filed 2026-02-17
-$63.00M
derived: sum of 3 quarters · filed 2026-02-17
-$129.00M
10-K · filed 2026-02-17
2024-09-30-$34.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
-$48.00M
derived: sum of 2 quarters · filed 2025-10-28
-$114.00M
10-Q · filed 2025-10-28
-$266.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30-$14.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22
-$80.00M
10-Q · filed 2025-07-22
-$232.00M
derived: sum of 3 quarters · filed 2026-02-17
-$279.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-03-31-$66.00M
10-Q · filed 2025-05-06
-$218.00M
derived: sum of 2 quarters · filed 2026-02-17
-$265.00M
derived: sum of 3 quarters · filed 2026-02-17
-$308.00M
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31-$152.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$199.00M
derived: sum of 2 quarters · filed 2026-02-17
-$242.00M
derived: sum of 3 quarters · filed 2026-02-17
-$269.00M
10-K · filed 2026-02-17
2023-09-30-$47.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
-$90.00M
derived: sum of 2 quarters · filed 2024-10-31
-$117.00M
10-Q · filed 2024-10-31
-$180.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30-$43.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22
-$70.00M
10-Q · filed 2024-07-22
-$133.00M
derived: sum of 3 quarters · filed 2025-02-13
-$157.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$27.00M
10-Q · filed 2024-05-02
-$90.00M
derived: sum of 2 quarters · filed 2025-02-13
-$114.00M
derived: sum of 3 quarters · filed 2025-02-13
-$132.00M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31-$63.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
-$87.00M
derived: sum of 2 quarters · filed 2025-02-13
-$105.00M
derived: sum of 3 quarters · filed 2025-02-13
-$115.00M
10-K · filed 2025-02-13
2022-09-30-$24.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$42.00M
derived: sum of 2 quarters · filed 2023-11-01
-$52.00M
10-Q · filed 2023-11-01
-$107.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30-$18.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$28.00M
10-Q · filed 2023-08-01
-$83.00M
derived: sum of 3 quarters · filed 2024-02-15
-$123.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31-$10.00M
10-Q · filed 2023-04-28
-$65.00M
derived: sum of 2 quarters · filed 2024-02-15
-$105.00M
derived: sum of 3 quarters · filed 2024-02-15
-$109.00M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31-$55.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
-$95.00M
derived: sum of 2 quarters · filed 2024-02-15
-$99.00M
derived: sum of 3 quarters · filed 2024-02-15
-$138.00M
10-K · filed 2024-02-15
2021-09-30-$40.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
-$44.00M
derived: sum of 2 quarters · filed 2022-10-27
-$83.00M
10-Q · filed 2022-10-27
-$99.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-06-30-$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22
-$43.00M
10-Q · filed 2022-07-22
-$59.00M
derived: sum of 3 quarters · filed 2023-02-15
-$117.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-03-31-$39.00M
10-Q · filed 2022-04-28
-$55.00M
derived: sum of 2 quarters · filed 2023-02-15
-$113.00M
derived: sum of 3 quarters · filed 2023-02-15
-$175.00M
derived: sum of 4 quarters · filed 2023-02-15
2020-12-31-$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15
-$74.00M
derived: sum of 2 quarters · filed 2023-02-15
-$136.00M
derived: sum of 3 quarters · filed 2023-02-15
-$176.00M
10-K · filed 2023-02-15
2020-09-30-$58.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22
-$120.00M
derived: sum of 2 quarters · filed 2021-10-22
-$160.00M
10-Q · filed 2021-10-22
-$163.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30-$62.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
-$102.00M
10-Q · filed 2021-07-28
-$105.00M
derived: sum of 3 quarters · filed 2022-02-16
-$193.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31-$40.00M
10-Q · filed 2021-04-23
-$43.00M
derived: sum of 2 quarters · filed 2022-02-16
-$131.00M
derived: sum of 3 quarters · filed 2022-02-16
-$185.00M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31-$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
-$91.00M
derived: sum of 2 quarters · filed 2022-02-16
-$145.00M
derived: sum of 3 quarters · filed 2022-02-16
-$157.00M
10-K · filed 2022-02-16
2019-09-30-$88.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22
-$142.00M
derived: sum of 2 quarters · filed 2020-10-22
-$154.00M
10-Q · filed 2020-10-22
-$148.00M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30-$54.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23
-$66.00M
10-Q · filed 2020-07-23
-$60.00M
derived: sum of 3 quarters · filed 2021-02-12
-$129.00M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31-$12.00M
10-Q · filed 2020-04-30
-$6.00M
derived: sum of 2 quarters · filed 2021-02-12
-$75.00M
derived: sum of 3 quarters · filed 2021-02-12
-$163.00M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
-$63.00M
derived: sum of 2 quarters · filed 2021-02-12
-$151.00M
derived: sum of 3 quarters · filed 2021-02-12
-$177.00M
10-K · filed 2021-02-12
2018-09-30-$69.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01
-$157.00M
derived: sum of 2 quarters · filed 2019-11-01
-$183.00M
10-Q · filed 2019-11-01
-$1.27B
derived: sum of 4 quarters · filed 2020-02-18
2018-06-30-$88.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
-$114.00M
10-Q · filed 2019-07-24
-$1.20B
derived: sum of 3 quarters · filed 2020-02-18
-$1.14B
derived: sum of 4 quarters · filed 2020-02-18
2018-03-31-$26.00M
10-Q · filed 2019-05-02
-$1.11B
derived: sum of 2 quarters · filed 2020-02-18
-$1.05B
derived: sum of 3 quarters · filed 2020-02-18
-$1.20B
derived: sum of 4 quarters · filed 2020-02-18
2017-12-31-$1.08B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18
-$1.02B
derived: sum of 2 quarters · filed 2020-02-18
-$1.17B
derived: sum of 3 quarters · filed 2020-02-18
-$1.22B
10-K · filed 2020-02-18
-$1.22B
10-K · filed 2018-02-16
2017-09-30$61.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25
-$85.00M
derived: sum of 2 quarters · filed 2018-10-25
-$137.00M
10-Q · filed 2018-10-25
-$139.00M
10-Q · filed 2017-10-27
-$18.00M
derived: sum of 4 quarters · filed 2019-02-19
2017-06-30-$146.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27
-$198.00M
10-Q · filed 2018-07-27
-$203.00M
10-Q · filed 2017-08-04
-$79.00M
derived: sum of 3 quarters · filed 2019-02-19
-$80.00M
derived: sum of 4 quarters · filed 2019-02-19
2017-03-31-$52.00M
10-Q · filed 2018-05-04
-$64.00M
10-Q · filed 2017-05-08
$67.00M
derived: sum of 2 quarters · filed 2019-02-19
$66.00M
derived: sum of 3 quarters · filed 2019-02-19
$58.00M
derived: sum of 4 quarters · filed 2019-02-19
2016-12-31$119.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19
$118.00M
derived: sum of 2 quarters · filed 2019-02-19
$110.00M
derived: sum of 3 quarters · filed 2019-02-19
$115.00M
10-K · filed 2019-02-19
$135.00M
10-K · filed 2017-02-16
2016-09-30-$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
-$9.00M
derived: sum of 2 quarters · filed 2017-10-27
-$4.00M
10-Q · filed 2017-10-27
-$4.22M
10-Q · filed 2016-11-03
-$9.25M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30-$8.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$3.00M
10-Q · filed 2017-08-04
-$2.65M
10-Q · filed 2016-07-27
-$8.25M
derived: sum of 3 quarters · filed 2018-02-16
$15.38M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31$5.00M
10-Q · filed 2017-05-08
$4.72M
10-Q · filed 2016-05-03
-$252.00K
derived: sum of 2 quarters · filed 2018-02-16
$23.38M
derived: sum of 3 quarters · filed 2018-02-16
$23.88M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31-$5.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$18.38M
derived: sum of 2 quarters · filed 2018-02-16
$18.88M
derived: sum of 3 quarters · filed 2018-02-16
$18.00M
10-K · filed 2018-02-16
$18.35M
10-K · filed 2016-02-11
2015-09-30$23.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$24.14M
derived: sum of 2 quarters · filed 2016-11-03
$23.25M
10-Q · filed 2016-11-03
$28.78M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-30$509.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27
-$375.00K
10-Q · filed 2016-07-27
$5.15M
derived: sum of 3 quarters · filed 2017-02-16
-$5.20M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-31-$884.00K
10-Q · filed 2016-05-03
$4.64M
derived: sum of 2 quarters · filed 2017-02-16
-$5.71M
derived: sum of 3 quarters · filed 2017-02-16
-$5.30M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31$5.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
-$4.83M
derived: sum of 2 quarters · filed 2017-02-16
-$4.41M
derived: sum of 3 quarters · filed 2017-02-16
-$6.00M
10-K · filed 2017-02-16
-$6.17M
10-K · filed 2015-02-12
2014-09-30-$10.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28
-$9.94M
derived: sum of 2 quarters · filed 2015-10-28
-$11.53M
10-Q · filed 2015-10-28
-$19.88M
derived: sum of 4 quarters · filed 2016-02-11
2014-06-30$414.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29
-$1.17M
10-Q · filed 2015-07-29
-$9.53M
derived: sum of 3 quarters · filed 2016-02-11
-$13.37M
derived: sum of 4 quarters · filed 2016-02-11
2014-03-31-$1.59M
10-Q · filed 2015-04-29
-$9.94M
derived: sum of 2 quarters · filed 2016-02-11
-$13.78M
derived: sum of 3 quarters · filed 2016-02-11
-$36.99M
derived: sum of 4 quarters · filed 2016-02-11
2013-12-31-$8.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11
-$12.20M
derived: sum of 2 quarters · filed 2016-02-11
-$35.40M
derived: sum of 3 quarters · filed 2016-02-11
-$24.24M
10-K · filed 2016-02-11
2013-09-30-$3.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
-$27.05M
derived: sum of 2 quarters · filed 2014-10-30
-$15.88M
10-Q · filed 2014-10-30
-$1.81M
derived: sum of 4 quarters · filed 2015-02-12
2013-06-30-$23.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
-$12.04M
10-Q · filed 2014-07-31
$2.03M
derived: sum of 3 quarters · filed 2015-02-12
-$3.33M
derived: sum of 4 quarters · filed 2015-02-12
2013-03-31$11.16M
10-Q · filed 2014-05-01
$25.23M
derived: sum of 2 quarters · filed 2015-02-12
$19.87M
derived: sum of 3 quarters · filed 2015-02-12
$23.92M
derived: sum of 4 quarters · filed 2015-02-12
2012-12-31$14.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12
$8.71M
derived: sum of 2 quarters · filed 2015-02-12
$12.76M
derived: sum of 3 quarters · filed 2015-02-12
$16.59M
10-K · filed 2015-02-12
2012-09-30-$5.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31
-$1.31M
derived: sum of 2 quarters · filed 2013-10-31
$2.52M
10-Q · filed 2013-10-31
2012-06-30$4.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
$7.88M
10-Q · filed 2013-08-01
2012-03-31$3.84M
10-Q · filed 2013-05-14
2011-12-31-$73.22M
10-K · filed 2014-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B